vesicular
stomat
viru
vsv
belong
famili
rhabdovirida
genu
vesiculoviru
vsv
envelop
bulletshap
viru
neg
singlestrand
rna
genom
encod
protein
nucleocapsid
n
phosphoprotein
p
matrix
protein
glycoprotein
g
larg
rnadepend
rna
polymeras
l
infecti
vsv
effici
recov
revers
genet
approach
util
multipl
plasmid
express
vsv
gene
sinc
develop
vsv
infecti
clone
vsv
consid
vaccin
vector
candid
due
inabl
undergo
genet
recombin
genet
reassort
absenc
transform
properti
furthermor
recombin
vsv
accommod
larg
multipl
foreign
gene
insert
genom
use
express
varieti
viral
antigen
recombin
elicit
strong
humor
cellmedi
immun
respons
upon
use
vaccin
also
mediat
protect
viru
challeng
mice
nonhuman
primat
along
abil
gener
robust
immun
respons
vsv
natur
infect
mucos
surfac
enabl
use
intranas
immun
induc
mucos
system
immun
natur
vsv
infect
caus
diseas
cattl
hors
swine
result
symptom
vesicular
lesion
around
mouth
hoof
teat
natur
infect
human
rare
report
agricultur
veterinari
context
also
report
laboratori
worker
infect
direct
exposur
vsv
although
human
infect
typic
subclin
result
mild
flulik
symptom
singl
case
enceph
panamanian
boy
associ
vsv
indiana
infect
document
neurotrop
neurovirul
also
demonstr
experiment
vsv
infect
rodent
base
neurolog
effect
research
object
shift
toward
develop
vsv
decreas
virul
use
human
vaccin
vector
attenu
vsv
undergo
singl
multipl
round
infect
viral
transcript
howev
possibl
induc
neurotox
therefor
develop
novel
strategi
elimin
viral
transcript
strongli
reduc
risk
vsv
neurotox
delet
p
gene
vsv
genom
p
gene
known
encod
essenti
cofactor
respons
activ
polymeras
complex
delet
p
gene
complet
abrog
transcript
vsv
infect
normal
cell
allow
host
immun
respons
activ
lead
safer
yet
equal
effect
vaccin
compar
wildtyp
vsv
abl
show
replic
strictli
support
cell
caus
neurovirul
mice
importantli
demonstr
express
hemagglutininneuraminidas
hn
newcastl
diseas
viru
ndv
hemagglutinin
ha
pandem
influenza
viru
avian
abl
incorpor
hn
ha
surfac
moreov
mice
immun
recombin
virus
gener
robust
immun
respons
similar
replicationcompet
counterpart
babi
hamster
kidney
bhk
cell
express
phosphoprotein
p
vsv
bhkp
grown
dmem
pan
biotech
germani
supplement
fetal
bovin
serum
fb
madindarbi
canin
kidney
mdck
human
embryon
kidney
hek
cell
grown
optimem
invitrogen
usa
supplement
fb
pubem
pmdg
kindli
provid
dr
yasuhiro
ikeda
mayo
clinic
usa
dr
john
rose
yale
univers
usa
influenza
virus
apuerto
prepar
embryon
chicken
egg
recombin
construct
previous
describ
use
ha
na
gene
access
number
background
recombin
virus
rescu
propag
previous
describ
construct
lentivir
vector
contain
p
gene
vsv
p
gene
amplifi
use
p
genespecif
primer
pcr
product
insert
pubem
gener
pubemp
lentiviru
harbor
p
gene
gener
base
method
describ
previous
use
transduc
cell
singl
clone
bhkp
cell
obtain
limit
dilut
encod
genom
vsv
indiana
serotyp
digest
ecorv
fig
p
gene
fragment
remov
rest
vsv
genom
selflig
construct
insert
mcherri
gene
clontech
usa
xhoi
nhei
site
similarli
gener
insert
hn
amplifi
ndv
strain
lasota
ha
amplifi
rna
ha
synthes
bio
basic
inc
canada
base
ha
respect
construct
pvsvhn
hn
ha
gene
insert
origin
posit
vsv
recov
base
method
describ
previous
bulk
amplif
plaquepurifi
vsv
subsequ
perform
infect
either
cell
vsv
bhkp
cell
moi
h
filter
supernat
centrifug
twice
sucros
cushion
rpm
sorval
fixedangl
rotor
h
pellet
virus
resuspend
pb
aliquot
store
vsv
stock
titrat
bhkp
cell
use
standard
plaqu
assay
bhkp
cell
cellswel
seed
overnight
inocul
moi
h
wash
pb
express
mcherri
emerald
protein
infect
cell
photograph
h
postinfect
use
fluoresc
microscop
subsequ
cell
harvest
fix
formaldehyd
subject
flow
cytometri
analysi
use
cytom
fc
mpl
beckman
coulter
usa
percentag
infect
cell
calcul
ratio
mcherryexpress
cell
total
cell
number
bhkp
cell
infect
either
vsv
moi
h
prior
wash
pb
supernat
collect
h
postinfect
viru
titer
determin
standard
plaqu
assay
detect
express
ha
viral
surfac
purifi
lyse
radioimmunoprecipit
assay
buffer
supplement
proteoblock
proteas
inhibitor
cocktail
thermo
scientif
usa
protein
electrophoret
separ
sodium
dodecyl
gel
ha
vsvg
protein
detect
western
blot
use
polyclon
antibodi
ha
sino
biolog
china
serum
vsvimmun
mice
respect
vrna
extract
supernat
cell
infect
vsv
use
viral
nucleic
acid
extract
kit
ii
geneaid
taiwan
viral
cdna
synthesi
perform
revertaid
premium
firststrand
cdna
synthesi
kit
thermo
scientif
distinguish
viral
rna
obtain
vsv
primer
cdna
synthesi
design
bind
end
n
gene
forward
primer
cagctcttctgctcagatccaccag
begin
gene
revers
primer
ttcagaccgagaatcttctttaaggaactc
ha
atctcgagatgaacactcaaatcctg
forward
primer
atgctagcttatatacaaatagtgcacc
revers
primer
vsvn
gctgatcaatgtctgttacagtcaagag
forward
primer
atgcggccgctcatttgtcaaattc
revers
primer
detect
use
specif
primer
procedur
approv
anim
care
use
committe
faculti
tropic
medicin
mahidol
univers
thailand
balbc
icr
mice
purchas
nation
laboratori
anim
center
mahidol
univers
vaccin
safeti
five
weekold
icr
mice
per
group
lightli
anesthet
ether
intracrani
inject
pfu
viru
mous
health
bodi
weight
monitor
daili
day
anim
exhibit
neurolog
symptom
limp
paralysi
etc
euthan
accord
institut
guidelin
record
show
lethal
respons
studi
immun
induct
five
weekold
balbc
mice
per
group
intraven
inject
pfu
viru
day
monitor
daili
vaccin
day
sera
harvest
test
immun
respons
induct
sera
serial
dilut
pb
ubottom
microtit
plate
thermo
scientif
four
ha
unit
influenza
viru
ad
well
incub
room
temperatur
h
follow
addit
human
typeo
red
blood
cell
hai
titer
calcul
reciproc
highest
dilut
serum
complet
inhibit
agglutin
red
blood
cell
sera
immun
mice
serial
dilut
plate
mix
influenza
viru
mixtur
incub
h
ad
monolay
mdck
cell
seed
plate
plate
incub
h
wash
media
tpcktrypsin
ad
well
plate
incub
anoth
h
supernat
analyz
ha
assay
viru
neutral
titer
defin
reciproc
highest
dilut
serum
show
complet
ha
titer
ninetysixwel
microtit
plate
coat
two
ha
unit
influenza
viru
dilut
bicarbon
coat
buffer
ph
block
fb
serial
dilut
sera
ad
well
haspecif
igg
detect
hrpconjug
goat
antimous
igg
kpl
usa
tetramethyl
benzidin
substrat
ad
readout
multiskan
fc
elisa
plate
reader
thermo
scientif
surviv
data
anim
studi
analyz
logrank
test
use
graphpad
prism
graphpad
softwar
usa
statist
signific
data
determin
student
ttest
hypothes
manipul
gene
vsv
genom
prevent
viru
replic
would
impair
viru
abil
induc
neurotox
first
engin
attenu
vsv
excis
p
gene
vsv
genom
ecorv
recogn
sequenc
p
gene
start
codon
gene
intergen
region
l
gene
fig
three
fragment
minu
p
gene
fragment
selflig
mcherri
gene
insert
g
l
gene
gener
fig
rescu
propag
construct
cell
stabli
express
p
bhkp
lentivir
transduct
fig
rescu
virus
confirm
p
gene
delet
rtpcr
viral
rna
fig
therebi
demonstr
success
construct
replic
support
bhkp
cell
demonstr
p
gene
delet
abrog
abil
vsv
replic
normal
cell
examin
express
emerald
bhkp
cell
mcherri
cell
protein
flow
cytometri
expect
exhibit
impair
replic
normal
cell
less
fluoresc
cell
detect
among
infect
cell
fig
contrast
almost
bhkp
cell
infect
investig
effect
p
gene
delet
viral
replic
vsv
use
infect
bhkp
cell
moi
supernat
harvest
variou
time
point
contrast
vsv
first
observ
h
postinfect
remain
least
log
lower
vsv
time
point
fig
consist
viral
replic
produc
smaller
plaqu
vsv
fig
plaqu
detect
h
postinfect
compar
h
postinfect
vsv
data
indic
pgene
delet
substanti
impair
viru
growth
vitro
thu
far
shown
attenu
fig
restrict
vitro
fig
investig
replic
attenu
vivo
mice
intracrani
inject
pfu
vsv
observ
neurolog
symptom
daili
mice
inject
vsv
began
limp
day
postinject
start
lose
weight
day
pronounc
weight
loss
day
p
contrast
mice
inject
signific
weight
loss
similar
mice
inject
pb
fig
although
bodi
weight
mice
inject
reduc
day
possibl
mild
neuropathogen
effect
viru
inject
neurolog
symptom
otherwis
observ
moreov
surviv
rate
mice
inject
significantli
greater
inject
vsv
p
fig
either
die
euthan
follow
neurolog
symptom
within
day
contrast
mice
inject
surviv
show
outward
sign
neurovirul
test
attenu
vaccin
vector
candid
construct
vsv
express
hn
ndv
lasota
strain
ha
pandem
influenza
viru
avian
vsv
express
hn
vsvhn
respect
fig
incorpor
hn
viral
surfac
demonstr
na
activ
fig
abil
inhibit
red
blood
cell
agglutin
ha
assay
fig
na
activ
detect
earli
h
postinfect
reach
highest
point
h
fig
demonstr
express
ha
vsv
express
ha
respect
fig
purifi
virus
analyz
ha
express
western
blot
analysi
ha
detect
vsv
express
ha
like
viral
surfac
fig
due
lack
commerci
ha
antibodi
check
incorpor
haencod
rna
vsv
express
ha
respect
fig
rtpcr
found
contain
ha
gene
viral
genom
p
gene
delet
fig
incorpor
foreign
glycoprotein
onto
viral
surfac
suggest
presenc
hn
ha
block
viral
assembl
examin
whether
insert
foreign
gene
interf
viru
replic
viru
growth
measur
time
vsv
could
detect
h
except
fig
similar
fig
replic
log
lower
pcontain
vsv
differ
becom
notic
h
taken
togeth
incorpor
foreign
glycoprotein
disrupt
viral
replic
compar
respect
parent
strain
virus
express
foreign
glycoprotein
viral
surfac
relev
elicit
immun
respons
surfac
antigen
final
test
whether
nonrepl
could
induc
immun
respons
foreign
antigen
ha
mice
immun
induc
antiha
igg
product
serum
titer
significantli
greater
mice
immun
fig
moreov
vsv
also
induc
neutral
antibodi
notabl
hai
titer
ha
shown
tabl
mice
immun
gener
viru
neutral
antibodi
titer
hai
titer
respect
strain
well
strain
data
shown
howev
crossreact
observ
heterolog
influenza
virus
similarli
sera
mice
immun
develop
signific
antiha
igg
level
compar
control
mice
fig
well
strong
neutral
antibodi
hai
titer
ha
tabl
mice
immun
sera
neutral
antibodi
hai
titer
respect
wherea
mice
immun
respect
crossreact
found
either
tabl
result
demonstr
immun
express
ha
induc
antiha
igg
neutral
antibodi
hai
titer
correspond
ha
fig
tabl
absenc
p
presenc
g
might
interfer
immun
induct
affect
ha
immun
induct
efficaci
studi
success
show
manipul
vsv
genom
delet
phosphoprotein
p
gene
attenu
viral
replic
vitro
led
decreas
pathogen
mice
monitor
weight
loss
paralysi
p
gene
encod
multifunct
protein
play
major
role
polymeras
activ
protect
l
proteolyt
degrad
support
effici
nascent
rna
encapsid
bind
newli
synthes
n
promot
viral
rna
synthesi
interact
termin
sequenc
viral
genom
p
gene
disrupt
would
therefor
abrog
vsv
replic
transcript
prevent
viral
protein
express
viral
progeni
product
gener
previous
report
muik
et
al
use
oncolyt
viru
show
vsv
p
gene
delet
could
propag
normal
cell
except
copropag
work
briefli
explor
characterist
viru
growth
kinet
titer
immun
induct
vivo
describ
despit
promis
natur
attenu
import
aspect
attenu
p
gene
delet
impact
viral
transcript
p
structur
protein
data
reveal
mcherri
express
cell
even
hour
infect
suggest
p
molecul
packag
viral
particl
insuffici
drive
appreci
level
protein
express
sign
neuropathogenesi
mice
intracrani
inject
observ
either
due
restrict
replic
pexpress
cell
presum
viral
replic
occur
mice
brain
tissu
viru
replic
brain
tissu
need
examin
overal
appear
replicationdefici
vitro
vivo
hand
vsv
attenu
strategi
elimin
vitro
viral
replic
schnell
et
al
report
vsv
attenu
g
cytoplasm
tail
ct
truncat
viru
still
capabl
replic
high
titer
cell
cultur
similarli
combin
methionin
delet
gene
g
cttruncat
yield
titer
pfuml
type
ifnsignalingcompet
cell
line
although
neurotox
found
vsvtreat
immunecompet
mice
virus
still
possess
intrins
abil
replic
possibl
vivo
replic
entir
dismiss
especi
immunecompromis
anim
replic
may
turn
present
risk
neuropatholog
p
gene
delet
also
practic
reason
first
rel
small
size
p
gene
delet
easili
common
restrict
enzym
without
compromis
vsv
genom
furthermor
unlik
vsv
protein
cell
line
stabli
express
p
easi
gener
stabl
express
p
littl
effect
cell
viabil
contrast
cell
perman
express
report
presum
due
associ
cytopath
effect
vsv
infect
microtubul
disassembl
lead
cell
round
similarli
g
capabl
mediat
cellcel
fusion
cell
line
stabli
constitut
express
g
simpli
viabl
induc
promot
system
report
techniqu
complic
technic
challeng
replic
effici
bhkp
cell
yield
still
lower
compar
vsv
counterpart
differ
expect
level
p
express
cell
line
like
lower
compar
amount
p
gener
wildtyp
viru
infect
addit
function
polymeras
cofactor
viral
rna
replic
transcript
p
need
phosphoryl
form
howev
p
bhkp
cell
might
properli
phosphoryl
therefor
may
less
effici
support
replic
may
possibl
improv
yield
strategi
use
stronger
promot
codon
optim
express
phosphomimet
p
nevertheless
yield
bhkp
cell
compar
induc
g
stabl
cell
line
express
gener
titer
rang
pfuml
shown
express
ha
viral
surfac
western
blot
analysi
howev
could
observ
hemagglutin
activ
data
shown
specul
red
blood
cell
bind
may
requir
presenc
ha
na
na
shown
remov
oligosaccharid
adjac
ha
receptorbind
pocket
therebi
facilit
bind
ha
sialic
acid
also
observ
previou
studi
use
vsv
express
ha
wsn
influenza
viru
viru
abl
bind
red
blood
cell
unless
cell
use
gener
viru
treat
na
observ
vsvhn
virus
possess
hemagglutinin
neuraminidas
function
exhibit
hemagglutin
activ
strongli
support
theori
gener
robust
immun
respons
similar
counterpart
viru
efficaci
presum
due
capac
singleround
entri
viral
surfac
present
ha
given
express
ha
surfac
unabl
replic
normal
cell
like
behav
similar
viruslik
particl
except
presenc
rna
genom
consequ
activ
tolllik
receptor
particularli
andor
could
enhanc
matur
dendrit
cell
cytotox
natur
killer
cell
heighten
immun
respons
foreign
glycoprotein
summari
demonstr
technolog
viabl
platform
viru
attenu
believ
p
gene
delet
strategi
may
appli
attenu
nonseg
negativesens
rna
virus
use
phosphoprotein
replic
rhabdoviru
paramyxoviru
bornaviru
